EUVIMEDEUVIMED entdecken
Crossref

Potency levels of regulated cannabis products in Michigan 2021–2022

Michele A Glinn, Gregoire P Michaud

Journal of Forensic Sciences · 2023

DOI: 10.1111/1556-4029.15345 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Forensic Sciences, 2023. Verfasst von Michele A Glinn und 1 weiteren Autor:innen. Beteiligte Einrichtung: Viridis Laboratories, Lansing, Michigan, USA. Hauptthemen laut MEDLINE: Cannabis, Cannabinoids, Hallucinogens, Cannabidiol. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Evaluation of cannabinoid concentrations in products from the legal cannabis market has been fraught with uncertainty. The lack of standardized testing methodology and the susceptibility of cannabinoids to degradation under certain storage conditions complicates the efforts to assess total tetrahydrocannabinol (THC) levels across wide geographic areas. There are few peer‐reviewed surveys of cannabinoid concentrations in regulated products. Those that have been done have not characterized the effects of differences in analytical methodology, sample population, and storage conditions. Viridis Laboratories, which operates two cannabis safety compliance facilities in Michigan, has analyzed over 34,000 cannabis products throughout 2021 and 2022 before the sale in the regulated market. Fifteen cannabinoids in cannabis flower, concentrates, and infused products were tested using methanolic extraction and analysis by high‐performance liquid chromatography with diode‐array detection. Methods were validated before use, and the flower analysis procedure was certified by the Association of Analytical Collaboration. All the samples were tested before submission for sale and therefore had not undergone prolonged storage. The results are compared with those seen in other states as well as in the illicit market. Total THC levels in cannabis flower from the regulated market are significantly higher than those seen in illicit products. The distribution of cannabinoid levels is similar in flowers intended for either the medicinal or adult‐use markets, with an average potency of 18%–23% of total THC. Total THC in concentrates averages up to 82%. Other cannabinoids are observed at significant levels, mostly in products specifically formulated to contain them. These results may act as a benchmark for potency levels in the regulated market.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabisCannabinoidsHallucinogensCannabidiolHumansAdultMichiganChromatography, High Pressure LiquidDronabinol

Stichwörter der Autor:innen

cannabidiolcannabisdelta-9-tetrahydrocannabinolpotencyregulated marketsafety compliance

Substanzen

CannabinoidsHallucinogensDronabinolCannabidiol

Autor:innen und Institutionen

  • Viridis Laboratories, Lansing, Michigan, USA.

Zitieren

APA

Glinn, M. A., & Michaud, G. P. (2023). Potency levels of regulated cannabis products in Michigan 2021–2022. Journal of Forensic Sciences. https://doi.org/10.1111/1556-4029.15345

Vancouver

Glinn MA, Michaud GP. Potency levels of regulated cannabis products in Michigan 2021–2022. Journal of Forensic Sciences. 2023. doi:10.1111/1556-4029.15345

BibTeX
@article{Glinn2023,
  author = {Glinn, Michele A and Michaud, Gregoire P},
  title = {Potency levels of regulated cannabis products in Michigan 2021–2022},
  journal = {Journal of Forensic Sciences},
  year = {2023},
  doi = {10.1111/1556-4029.15345}
}
Kostenlos starten →